CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Pooled Analysis of Bleeding, Major Adverse Cardiovascular Events, and All-Cause Mortality in Clinical Trials of Time-Constrained Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention Acute Coronary Syndrome, Antiplatelet Therapy, and Bleeding: A Clinical Perspective Acute Aortic Syndrome Revisited: JACC State-of-the-Art Review Percutaneous coronary intervention in left main coronary artery disease: the 13th consensus document from the European Bifurcation Club Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease : A Special Report From the American Heart Association and American College of Cardiology Revascularization of left main coronary artery 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Benefit-risk profile of extended dual antiplatelet therapy beyond 1 year in patients with high risk of ischemic or bleeding events after PCI Dual-Antiplatelet Therapy Cessation and Cardiovascular Risk in Relation to Age: Analysis From the PARIS Registry Rivaroxaban Plus Aspirin in Patients With Vascular Disease and Renal Dysfunction: From the COMPASS Trial

GuidelineEuropean Heart Journal (2023) 00, 1–107

JOURNAL:European Heart Journal. Article Link

2023 ESC Guidelines for the management of acute coronary syndromes

RA Byrne, B Ibanez, ESC Scientific Document Group. Keywords: ACS; guideline

Full Text PDF